Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00285545 · ClinicalTrials.gov registry record
Biomagnetic Signals of Intestinal Ischemia
A clinical trial, sponsored by University of South Alabama.
- Completed
- Registry status
- 60
- Enrollment target
NCT00285545: Completed study, sponsored by University of South Alabama.
NCT00285545 is a clinical trial that has completed, run by University of South Alabama. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00285545 has completed, sponsored by University of South Alabama.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The lack of blood flow to the small intestine causes mesenteric ischemia. Using a Superconducting QUantum Interference Device (SQUID) which measures the magnetic field of the small intestine, we are hoping to identify abnormalities without surgical intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2000-01 |
| Est. Completion | 2013-01 |
What the finished NCT00285545 record still lists
NCT00285545 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00285545 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00285545 about?
NCT00285545 is a clinical study titled "Biomagnetic Signals of Intestinal Ischemia". The lack of blood flow to the small intestine causes mesenteric ischemia. Using a Superconducting QUantum Interference Device (SQUID) which measures the magnetic field of the small intestine, we are hoping to identify abnormalities without surgical intervention.
What is the current status of trial NCT00285545?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2000-01. Estimated completion is 2013-01.
Who is sponsoring clinical trial NCT00285545?
This trial is sponsored by University of South Alabama, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia